Annual Gross Profit
$24.52 M
+$14.58 M+146.66%
December 31, 2023
Summary
- As of February 7, 2025, ZVRA annual gross profit is $24.52 million, with the most recent change of +$14.58 million (+146.66%) on December 31, 2023.
- During the last 3 years, ZVRA annual gross profit has risen by +$12.53 million (+104.59%).
- ZVRA annual gross profit is now -7.80% below its all-time high of $26.59 million, reached on December 31, 2021.
Performance
ZVRA Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$1.39 M
+$516.00 K+58.90%
September 30, 2024
Summary
- As of February 7, 2025, ZVRA quarterly gross profit is $1.39 million, with the most recent change of +$516.00 thousand (+58.90%) on September 30, 2024.
- Over the past year, ZVRA quarterly gross profit has dropped by -$9.53 million (-87.25%).
- ZVRA quarterly gross profit is now -87.48% below its all-time high of $11.12 million, reached on March 1, 2021.
Performance
ZVRA Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$16.44 M
-$1.36 M-7.64%
September 30, 2024
Summary
- As of February 7, 2025, ZVRA TTM gross profit is $16.44 million, with the most recent change of -$1.36 million (-7.64%) on September 30, 2024.
- Over the past year, ZVRA TTM gross profit has dropped by -$8.08 million (-32.95%).
- ZVRA TTM gross profit is now -38.18% below its all-time high of $26.59 million, reached on December 1, 2021.
Performance
ZVRA TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
ZVRA Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +146.7% | -87.3% | -33.0% |
| 3 y3 years | +104.6% | -87.3% | -33.0% |
| 5 y5 years | +100.0% | -87.3% | -33.0% |
ZVRA Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.8% | +146.7% | -87.3% | +58.9% | -38.2% | +82.0% |
| 5 y | 5-year | -7.8% | +147.8% | -87.5% | +344.6% | -38.2% | +82.0% |
| alltime | all time | -7.8% | -100.0% | -87.5% | +344.6% | -38.2% | -100.0% |
Zevra Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.39 M(+58.9%) | $16.44 M(-7.6%) |
| Jun 2024 | - | $876.00 K(-73.0%) | $17.80 M(-28.0%) |
| Mar 2024 | - | $3.25 M(-70.2%) | $24.71 M(+0.8%) |
| Dec 2023 | $24.52 M(+146.7%) | $10.92 M(+297.0%) | $24.52 M(+57.2%) |
| Sep 2023 | - | $2.75 M(-64.7%) | $15.60 M(+0.1%) |
| Jun 2023 | - | $7.79 M(+155.4%) | $15.58 M(+72.4%) |
| Mar 2023 | - | $3.05 M(+52.5%) | $9.03 M(-9.1%) |
| Dec 2022 | $9.94 M(-62.6%) | $2.00 M(-26.8%) | $9.94 M(-5.0%) |
| Sep 2022 | - | $2.73 M(+118.8%) | $10.46 M(+7.9%) |
| Jun 2022 | - | $1.25 M(-68.4%) | $9.69 M(-50.1%) |
| Mar 2022 | - | $3.96 M(+56.8%) | $19.43 M(-26.9%) |
| Dec 2021 | $26.59 M | - | - |
| Dec 2021 | - | $2.52 M(+28.4%) | $26.59 M(+0.6%) |
| Sep 2021 | - | $1.97 M(-82.1%) | $26.43 M(+0.2%) |
| Jun 2021 | - | $10.99 M(-1.2%) | $26.39 M(+21.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $11.12 M(+369.9%) | $21.67 M(+80.9%) |
| Dec 2020 | $11.98 M(+21.1%) | $2.37 M(+22.9%) | $11.98 M(+32.4%) |
| Sep 2020 | - | $1.93 M(-69.3%) | $9.05 M(-48.5%) |
| Jun 2020 | - | $6.27 M(+339.4%) | $17.59 M(+55.4%) |
| Mar 2020 | - | $1.43 M(-350.6%) | $11.32 M(+14.4%) |
| Dec 2019 | $9.89 M(>+9900.0%) | -$569.00 K(-105.4%) | $9.89 M(-5.4%) |
| Sep 2019 | - | $10.46 M(>+9900.0%) | $10.46 M(>+9900.0%) |
| Jun 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $0.00 | - | - |
FAQ
- What is Zevra Therapeutics annual gross profit?
- What is the all time high annual gross profit for Zevra Therapeutics?
- What is Zevra Therapeutics annual gross profit year-on-year change?
- What is Zevra Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly gross profit year-on-year change?
- What is Zevra Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Zevra Therapeutics?
- What is Zevra Therapeutics TTM gross profit year-on-year change?
What is Zevra Therapeutics annual gross profit?
The current annual gross profit of ZVRA is $24.52 M
What is the all time high annual gross profit for Zevra Therapeutics?
Zevra Therapeutics all-time high annual gross profit is $26.59 M
What is Zevra Therapeutics annual gross profit year-on-year change?
Over the past year, ZVRA annual gross profit has changed by +$14.58 M (+146.66%)
What is Zevra Therapeutics quarterly gross profit?
The current quarterly gross profit of ZVRA is $1.39 M
What is the all time high quarterly gross profit for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly gross profit is $11.12 M
What is Zevra Therapeutics quarterly gross profit year-on-year change?
Over the past year, ZVRA quarterly gross profit has changed by -$9.53 M (-87.25%)
What is Zevra Therapeutics TTM gross profit?
The current TTM gross profit of ZVRA is $16.44 M
What is the all time high TTM gross profit for Zevra Therapeutics?
Zevra Therapeutics all-time high TTM gross profit is $26.59 M
What is Zevra Therapeutics TTM gross profit year-on-year change?
Over the past year, ZVRA TTM gross profit has changed by -$8.08 M (-32.95%)